This is the authors' abstract. We don't add key points for this paper.
These results suggest that the metastatic, aggressive behavior of IBC may be mediated by a CSC component that displays ALDH enzymatic activity. ALDH1 expression represents the first independent prognostic marker to predict metastasis and poor patient outcome in IBC. The results illustrate how stem cell research can translate into clinical practice in the IBC field.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Charafe‐Jauffret et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: